Home › Compare › PTEC vs MRK

PTEC vs MRK: Dividend Comparison 2026

PTEC yields 100.76% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTEC wins by $3.99M in total portfolio value
10 years
PTEC
PTEC
● Live price
100.76%
Share price
$39.56
Annual div
$39.86
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.02M
Annual income
$1,361,268.30
Full PTEC calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — PTEC vs MRK

📍 PTEC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTECMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTEC + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PTEC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTEC
Annual income on $10K today (after 15% tax)
$8,564.79/yr
After 10yr DRIP, annual income (after tax)
$1,157,078.06/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, PTEC beats the other by $1,156,270.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTEC + MRK for your $10,000?

PTEC: 50%MRK: 50%
100% MRK50/50100% PTEC
Portfolio after 10yr
$2.02M
Annual income
$681,109.30/yr
Blended yield
33.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PTEC
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTEC buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTECMRK
Forward yield100.76% ✓3.25%
Annual dividend / share$39.86 ✓$3.08
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.02M$30.7K ✓
Annual income after 10y$1,361,268.30 ✓$950.29
Total dividends collected$3.59M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTEC vs MRK ($10,000, DRIP)

YearPTEC PortfolioPTEC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,776$10,076.22$11,192$351.54+$9.6K → PTEC
2$41,796$19,565.03$12,524$392.70+$29.3K → PTEC
3$81,505$36,784.15$14,015$438.65+$67.5K → PTEC
4$154,251$67,039.85$15,682$489.96+$138.6K → PTEC
5$283,622$118,574.07$17,547$547.23+$266.1K → PTEC
6$507,236$203,760.15$19,632$611.16+$487.6K → PTEC
7$883,312$340,569.06$21,963$682.53+$861.3K → PTEC
8$1,499,418$554,274.97$24,571$762.18+$1.47M → PTEC
9$2,483,705$879,326.96$27,486$851.08+$2.46M → PTEC
10$4,018,832$1,361,268.30$30,745$950.29+$3.99M → PTEC

PTEC vs MRK: Complete Analysis 2026

PTEC — Stock

The fund invests at least 80% of its net assets, plus borrowings for investments purposes (if any), in the securities of the Global X PropTech Index, which may include common stocks, American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is owned and was developed by Global X Management Company LLC, an affiliate of the fund and the fund's investment adviser. The fund is non-diversified.

Full PTEC Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this PTEC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTEC vs SCHDPTEC vs JEPIPTEC vs OPTEC vs KOPTEC vs MAINPTEC vs JNJPTEC vs ABBVPTEC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.